These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17192639)

  • 1. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes.
    Jones IW; Westmacott A; Chan E; Jones RW; Dineley K; O'Neill MJ; Wonnacott S
    J Mol Neurosci; 2006; 30(1-2):83-4. PubMed ID: 17192639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of the partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease.
    Liou YJ; Lai IC; Hong CJ; Liu HC; Liu TY; Tsai SJ
    Dement Geriatr Cogn Disord; 2001; 12(5):301-4. PubMed ID: 11455129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo.
    Bitner RS; Nikkel AL; Markosyan S; Otte S; Puttfarcken P; Gopalakrishnan M
    Brain Res; 2009 Apr; 1265():65-74. PubMed ID: 19230830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein.
    Wevers A; Monteggia L; Nowacki S; Bloch W; Schütz U; Lindstrom J; Pereira EF; Eisenberg H; Giacobini E; de Vos RA; Steur EN; Maelicke A; Albuquerque EX; Schröder H
    Eur J Neurosci; 1999 Jul; 11(7):2551-65. PubMed ID: 10383644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of APP(SWE) transfection on nicotinic receptors in cultured neuronal cells].
    An Y; Tang Z; Qi XL; Xiao Y; Shan KR; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):48-51. PubMed ID: 20388400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide.
    Lamb PW; Melton MA; Yakel JL
    J Mol Neurosci; 2005; 27(1):13-21. PubMed ID: 16055943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL; Nordberg A; Xiu J; Guan ZZ
    Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
    Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
    Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.
    Dziewczapolski G; Glogowski CM; Masliah E; Heinemann SF
    J Neurosci; 2009 Jul; 29(27):8805-15. PubMed ID: 19587288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.